Not applicableLooking for participantsNCT07769827What this trial is testingPeg IFNα-2b Therapy for Unresectable Mid to Late Stage HBV-HCCWho this might be right forHBV-HCCUnresectable Advanced HBV-related Liver Cancer Jinling Hospital, China 33